PNRR Missione 4 – MUR

Avviso pubblico “Partenariati Estesi”

INF ACT” One Health Basic and Translational Research Actions addressing Unmet Needs on Emerging Infectious Diseases

PNRR Missione 6 – Ministero della Salute

Avviso pubblico “Valorizzazione e potenziamento della ricerca biomedica del SSN”

A dynamic evaluation of chronic heart failure prognosis: the MECKI score

Hypothermic Oxygenated Perfusion To Reduce Tumour Recurrence After Liver Transplantation In Patients With Hepatocarcinoma

Spine Unit modelling coupled with hIgh Throughput analysis (SUIT): targeting degeneration with cell secretom

Exploiting the power of human induced pluripotent stem cell extracellular vesicles as a new anti-inflammatory drug for lung ischemia reperfusion injury

A 360-degree view of integrated diagnostic tools for precise pancreatic cancer diagnosis and prediction of response to treatment

“Benign and malignant esophageal stricture, an innovative approach to address an unmet clinical need: a biohybrid polymer – extracellular matrix, drug-eluting, esophageal prosthesis able to provide sustained mechanical support, actively prevent re-stenosis and induce constructive tissue remodeling”

A new versatile technological Bioartificial drug-eluting caRdiac pAtch to preVEnt HEART failure: fromclinically-oriented de-risking activity to the industrial prototyping and preclinical validation (BRAVEHEART)

Re-designing biliary atresia care pathways in Italy: a multicentric national co-operative model

Contrasting chronic inflammation and neurodegeneration using the human amniotic mesenchymal cell secretome as an innovative therapeutic strategy (CONTRAST-OME)

Fibrin gel loaded with extracellular vesicles for the treatment of cartilage lesions in degenerative joint conditions

Early Drug Discovery to identify novel inhibitors of Prenylcysteine oxidase 1 (PCYOX1), a novel target in cardiology and oncology

Treatment of ischemic cardiomyopathy with novel anti remodeling proteins and clinical grade exosomes derived from amniotic mesenchymal stromal cells

Clinical validation of a machine learning-based biomarkers signature to predict response to therapy in metastatic colorectal cancer patients

Organoid models of hepatocellular carcinoma to test treatment efficacy, exploring correlations with tumor microenvironment and gut-liver-tumor axis

Speed-up the diagnosis and evaluation of anoMalous coronary ARTery from the aorta (SMART)

Integration of multiomics markers for invasive IPMNs identification through the set-up of the INvasive Cyst bIomarkers detection (INCITE) consortium

Innovative neuromodulation treatments for chronic pain: assessing and predicting the effects of personalized High-Definition protocols for transcranial Direct Current Stimulation (HD-tDCS)